PINE Alpine Income Property Trust | $15.27 +0.6% | 4/21/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $23.00 | Low | View details for EF Hutton Acquisition Co. I rating of Alpine Income Property Trust (NYSE:PINE) on 4/21/2023 |
SWAG Stran & Company, Inc. | $1.46 +0.7% | 4/21/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $4.50 | Low | View details for EF Hutton Acquisition Co. I rating of Stran & Company, Inc. (NASDAQ:SWAG) on 4/21/2023 |
DRCT Direct Digital | $15.24 -5.0% | 4/20/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $5.50 | Low | View details for EF Hutton Acquisition Co. I rating of Direct Digital (NASDAQ:DRCT) on 4/20/2023 |
INVA Innoviva | $15.24 -0.3% | 4/20/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $22.50 | Low | View details for EF Hutton Acquisition Co. I rating of Innoviva (NASDAQ:INVA) on 4/20/2023 |
TUSK Mammoth Energy Services | $3.64 +0.3% | 4/20/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Mammoth Energy Services (NASDAQ:TUSK) on 4/20/2023 |
BCYC Bicycle Therapeutics | $24.90 +1.4% | 4/19/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $55.00 | Low | View details for EF Hutton Acquisition Co. I rating of Bicycle Therapeutics (NASDAQ:BCYC) on 4/19/2023 |
|
HCWB HCW Biologics | $1.75 -0.6% | 4/19/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of HCW Biologics (NASDAQ:HCWB) on 4/19/2023 |
SPI SPI Energy | $0.62 +3.3% | 4/19/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of SPI Energy (NASDAQ:SPI) on 4/19/2023 |
INAB IN8bio | $1.18 -2.5% | 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of IN8bio (NASDAQ:INAB) on 4/17/2023 |
CMCT Creative Media & Community Trust Co. | $4.26 +1.4% | 4/17/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $5.00 -> $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Creative Media & Community Trust Co. (NASDAQ:CMCT) on 4/17/2023 |
ALLO Allogene Therapeutics | $4.47 +0.2% | 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Allogene Therapeutics (NASDAQ:ALLO) on 4/17/2023 |
IPSC Century Therapeutics | $4.18 -2.1% | 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $16.00 | Low | View details for EF Hutton Acquisition Co. I rating of Century Therapeutics (NASDAQ:IPSC) on 4/17/2023 |
BCAB BioAtla | $3.44 -0.6% | 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of BioAtla (NASDAQ:BCAB) on 4/17/2023 |
MNMD Mind Medicine (MindMed) | $9.40 -1.1% | 4/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 4/14/2023 |
MRUS Merus | $45.03 +0.6% | 4/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of Merus (NASDAQ:MRUS) on 4/14/2023 |
USEG U.S. Energy | $1.08 +1.9% | 4/14/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $3.50 -> $3.00 | Low | View details for EF Hutton Acquisition Co. I rating of U.S. Energy (NASDAQ:USEG) on 4/14/2023 |
ADAP Adaptimmune Therapeutics | $1.58
| 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 4/17/2023 |
CRSP CRISPR Therapeutics | $68.16 -2.9% | 4/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $75.00 | Low | View details for EF Hutton Acquisition Co. I rating of CRISPR Therapeutics (NASDAQ:CRSP) on 4/17/2023 |
OPT Opthea | $4.11 +5.1% | 4/17/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $23.00 | Low | View details for EF Hutton Acquisition Co. I rating of Opthea (NASDAQ:OPT) on 4/17/2023 |
CMPS COMPASS Pathways | $8.32 -12.4% | 4/12/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $38.00 | Low | View details for EF Hutton Acquisition Co. I rating of COMPASS Pathways (NASDAQ:CMPS) on 4/12/2023 |
BFI BurgerFi International | $0.58 -9.4% | 4/11/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $2.50 | Low | View details for EF Hutton Acquisition Co. I rating of BurgerFi International (NASDAQ:BFI) on 4/11/2023 |
ADAP Adaptimmune Therapeutics | $1.58
| 4/11/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 4/11/2023 |
BMEA Biomea Fusion | $14.95 -2.7% | 4/6/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $33.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Biomea Fusion (NASDAQ:BMEA) on 4/6/2023 |
ISSC Innovative Solutions and Support | $7.32 +3.1% | 4/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $11.00 | Low | View details for EF Hutton Acquisition Co. I rating of Innovative Solutions and Support (NASDAQ:ISSC) on 4/5/2023 |
COEP Coeptis Therapeutics | $0.30
| 4/5/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of Coeptis Therapeutics (NASDAQ:COEP) on 4/5/2023 |
OMEX Odyssey Marine Exploration | $3.81 -5.0% | 4/5/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.50 | Low | View details for EF Hutton Acquisition Co. I rating of Odyssey Marine Exploration (NASDAQ:OMEX) on 4/5/2023 |
CRSP CRISPR Therapeutics | $68.16 -2.9% | 4/3/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $75.00 | Low | View details for EF Hutton Acquisition Co. I rating of CRISPR Therapeutics (NASDAQ:CRSP) on 4/3/2023 |
HOUR Hour Loop | $1.13 -8.1% | 4/3/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy -> Hold | $5.00 -> $2.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hour Loop (NASDAQ:HOUR) on 4/3/2023 |
SHFS SHF | $0.97 -3.0% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.50 -> $1.50 | Low | View details for EF Hutton Acquisition Co. I rating of SHF (NASDAQ:SHFS) on 3/31/2023 |
CMCT Creative Media & Community Trust Co. | $4.26 +1.4% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.00 -> $5.00 | Low | View details for EF Hutton Acquisition Co. I rating of Creative Media & Community Trust Co. (NASDAQ:CMCT) on 3/31/2023 |
UNCY Unicycive Therapeutics | $1.38 -5.5% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/31/2023 |
PED PEDEVCO | $0.80
| 3/30/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.40 | N/A | View details for EF Hutton Acquisition Co. I rating of PEDEVCO (NYSEAMERICAN:PED) on 3/30/2023 |
HCWB HCW Biologics | $1.75 -0.6% | 3/30/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of HCW Biologics (NASDAQ:HCWB) on 3/30/2023 |
ATAI Atai Life Sciences | $1.97 +10.1% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Atai Life Sciences (NASDAQ:ATAI) on 3/31/2023 |
HSON Hudson Global | $17.65 -2.5% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $42.50 | N/A | View details for EF Hutton Acquisition Co. I rating of Hudson Global (NASDAQ:HSON) on 3/31/2023 |
SWAG Stran & Company, Inc. | $1.46 +0.7% | 3/31/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $4.50 | N/A | View details for EF Hutton Acquisition Co. I rating of Stran & Company, Inc. (NASDAQ:SWAG) on 3/31/2023 |
SACH Sachem Capital | $4.44 -0.7% | 3/31/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $5.00 -> $4.50 | N/A | View details for EF Hutton Acquisition Co. I rating of Sachem Capital (NYSEAMERICAN:SACH) on 3/31/2023 |
AGEN Agenus | $0.58 +3.6% | 3/28/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Agenus (NASDAQ:AGEN) on 3/28/2023 |
GIPR Generation Income Properties | $3.83 +2.7% | 3/28/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 -> $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of Generation Income Properties (NASDAQ:GIPR) on 3/28/2023 |
BMEA Biomea Fusion | $14.95 -2.7% | 3/28/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $22.00 -> $33.00 | Low | View details for EF Hutton Acquisition Co. I rating of Biomea Fusion (NASDAQ:BMEA) on 3/28/2023 |
This consistently signaled gains of 453%... 610%... and even 1036%... (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
INAB IN8bio | $1.18 -2.5% | 3/29/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of IN8bio (NASDAQ:INAB) on 3/29/2023 |
SELF Global Self Storage | $4.45 +1.6% | 3/29/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Global Self Storage (NASDAQ:SELF) on 3/29/2023 |
ENVX Enovix | $8.01 -0.2% | 3/29/2023 | Reiterated by | EF Hutton Acquisition Co. I | Analyst Chip Moore | Buy | $18.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Enovix (NASDAQ:ENVX) on 3/29/2023 |
COEP Coeptis Therapeutics | $0.30
| 3/29/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Coeptis Therapeutics (NASDAQ:COEP) on 3/29/2023 |
MNPR Monopar Therapeutics | $0.68 -8.1% | 3/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Monopar Therapeutics (NASDAQ:MNPR) on 3/24/2023 |
AMPX Amprius Technologies | $2.64
| 3/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $14.00 | Low | View details for EF Hutton Acquisition Co. I rating of Amprius Technologies (NYSE:AMPX) on 3/24/2023 |
HOWL Werewolf Therapeutics | $6.48 +2.0% | 3/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Werewolf Therapeutics (NASDAQ:HOWL) on 3/24/2023 |
BCAB BioAtla | $3.44 -0.6% | 3/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of BioAtla (NASDAQ:BCAB) on 3/24/2023 |
HCWB HCW Biologics | $1.75 -0.6% | 3/23/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of HCW Biologics (NASDAQ:HCWB) on 3/23/2023 |
CLNN Clene | $0.43
| 3/23/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Clene (NASDAQ:CLNN) on 3/23/2023 |
PED PEDEVCO | $0.80
| 3/23/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.40 | N/A | View details for EF Hutton Acquisition Co. I rating of PEDEVCO (NYSEAMERICAN:PED) on 3/23/2023 |
REGN Regeneron Pharmaceuticals | $962.49 -0.4% | 3/23/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $853.00 -> $862.00 | Low | View details for EF Hutton Acquisition Co. I rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 3/23/2023 |
LTRN Lantern Pharma | $8.80 -10.0% | 3/21/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $11.00 | Low | View details for EF Hutton Acquisition Co. I rating of Lantern Pharma (NASDAQ:LTRN) on 3/21/2023 |
BMEA Biomea Fusion | $14.95 -2.7% | 3/21/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $22.00 | Low | View details for EF Hutton Acquisition Co. I rating of Biomea Fusion (NASDAQ:BMEA) on 3/21/2023 |
VNRX VolitionRx | $0.76 +1.3% | 3/16/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | N/A | View details for EF Hutton Acquisition Co. I rating of VolitionRx (NYSEAMERICAN:VNRX) on 3/16/2023 |
GMGI Golden Matrix Group | $2.86 -2.7% | 3/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $4.00 | Low | View details for EF Hutton Acquisition Co. I rating of Golden Matrix Group (NASDAQ:GMGI) on 3/17/2023 |
SGC Superior Group of Companies | $16.52 -1.0% | 3/17/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $20.00 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Superior Group of Companies (NASDAQ:SGC) on 3/17/2023 |
TTI TETRA Technologies | $4.42
| 3/16/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $8.50 -> $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of TETRA Technologies (NYSE:TTI) on 3/16/2023 |
IPSC Century Therapeutics | $4.18 -2.1% | 3/16/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $16.00 | Low | View details for EF Hutton Acquisition Co. I rating of Century Therapeutics (NASDAQ:IPSC) on 3/16/2023 |
BRT BRT Apartments | $16.81 +2.2% | 3/15/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $27.00 -> $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of BRT Apartments (NYSE:BRT) on 3/15/2023 |
OMEX Odyssey Marine Exploration | $3.81 -5.0% | 3/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.50 | Low | View details for EF Hutton Acquisition Co. I rating of Odyssey Marine Exploration (NASDAQ:OMEX) on 3/14/2023 |
OLP One Liberty Properties | $22.64 +0.8% | 3/14/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $28.00 -> $27.00 | Low | View details for EF Hutton Acquisition Co. I rating of One Liberty Properties (NYSE:OLP) on 3/14/2023 |
CMT Core Molding Technologies | $18.99 +2.4% | 3/14/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $16.00 -> $19.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Core Molding Technologies (NYSEAMERICAN:CMT) on 3/14/2023 |
AGEN Agenus | $0.58 +3.6% | 3/15/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Agenus (NASDAQ:AGEN) on 3/15/2023 |
MDRR Medalist Diversified REIT | $5.77 -0.3% | 3/13/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Medalist Diversified REIT (NASDAQ:MDRR) on 3/13/2023 |
SDPI Superior Drilling Products | $0.91 +2.2% | 3/13/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Superior Drilling Products (NYSE:SDPI) on 3/13/2023 |
LMB Limbach | $41.42 -0.5% | 3/10/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $15.00 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Limbach (NASDAQ:LMB) on 3/10/2023 |
MNMD Mind Medicine (MindMed) | $9.40 -1.1% | 3/10/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 3/10/2023 |
KLXE KLX Energy Services | $7.74 +6.2% | 3/10/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $30.00 | Low | View details for EF Hutton Acquisition Co. I rating of KLX Energy Services (NASDAQ:KLXE) on 3/10/2023 |
WLDN Willdan Group | $28.99 -0.7% | 3/10/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Willdan Group (NASDAQ:WLDN) on 3/10/2023 |
CVM CEL-SCI | $1.91 +1.1% | 3/9/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | N/A | View details for EF Hutton Acquisition Co. I rating of CEL-SCI (NYSE:CVM) on 3/9/2023 |
HDSN Hudson Technologies | $11.01 -1.2% | 3/9/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $13.00 -> $14.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hudson Technologies (NASDAQ:HDSN) on 3/9/2023 |
UNCY Unicycive Therapeutics | $1.38 -5.5% | 3/9/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $5.00 | Low | View details for EF Hutton Acquisition Co. I rating of Unicycive Therapeutics (NASDAQ:UNCY) on 3/9/2023 |
ONL Orion Office REIT | $3.51 +2.3% | 3/9/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $13.00 -> $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Orion Office REIT (NYSE:ONL) on 3/9/2023 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 3/9/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $68.50 | Low | View details for EF Hutton Acquisition Co. I rating of Jasper Therapeutics (NASDAQ:JSPR) on 3/9/2023 |
REFI Chicago Atlantic Real Estate Finance | $15.77 +0.5% | 3/9/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $20.00 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Chicago Atlantic Real Estate Finance (NASDAQ:REFI) on 3/9/2023 |
CLNN Clene | $0.43
| 3/8/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Clene (NASDAQ:CLNN) on 3/8/2023 |
INTT inTEST | $13.25 +16.5% | 3/8/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $22.00 | N/A | View details for EF Hutton Acquisition Co. I rating of inTEST (NYSE:INTT) on 3/8/2023 |
AMPX Amprius Technologies | $2.64
| 3/7/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $14.00 | Low | View details for EF Hutton Acquisition Co. I rating of Amprius Technologies (NYSE:AMPX) on 3/7/2023 |
ATAI Atai Life Sciences | $1.97 +10.1% | 3/7/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Atai Life Sciences (NASDAQ:ATAI) on 3/7/2023 |
AFCG AFC Gamma | $12.38 -1.0% | 3/8/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $22.00 -> $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of AFC Gamma (NASDAQ:AFCG) on 3/8/2023 |
ADAP Adaptimmune Therapeutics | $1.58
| 3/6/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/6/2023 |
EXEL Exelixis | $23.73 -0.5% | 3/3/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Exelixis (NASDAQ:EXEL) on 3/3/2023 |
INVA Innoviva | $15.24 -0.3% | 3/3/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $22.50 | Low | View details for EF Hutton Acquisition Co. I rating of Innoviva (NASDAQ:INVA) on 3/3/2023 |
GWH ESS Tech | $0.73 -2.7% | 3/2/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $6.00 -> $4.00 | Low | View details for EF Hutton Acquisition Co. I rating of ESS Tech (NYSE:GWH) on 3/2/2023 |
LXFR Luxfer | $10.37 -1.1% | 3/2/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Luxfer (NYSE:LXFR) on 3/2/2023 |
GHRS GH Research | $10.66 -0.5% | 3/2/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $33.00 | Low | View details for EF Hutton Acquisition Co. I rating of GH Research (NASDAQ:GHRS) on 3/2/2023 |
TTI TETRA Technologies | $4.42
| 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.50 | Low | View details for EF Hutton Acquisition Co. I rating of TETRA Technologies (NYSE:TTI) on 3/1/2023 |
UMH UMH Properties | $16.24 +2.5% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of UMH Properties (NYSE:UMH) on 3/1/2023 |
FATE Fate Therapeutics | $7.34
| 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Fate Therapeutics (NASDAQ:FATE) on 3/1/2023 |
Central Banks Preparing for US Dollar Collapse? (Ad) China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying.
Their ultimate goal? Ditching the greenback in favor of local BRICS currencies. Find out how you can protect yourself now >>> |
MRUS Merus | $45.03 +0.6% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of Merus (NASDAQ:MRUS) on 3/1/2023 |
ALLO Allogene Therapeutics | $4.47 +0.2% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Allogene Therapeutics (NASDAQ:ALLO) on 3/1/2023 |
HY Hyster-Yale Materials Handling | $64.19 +2.0% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $75.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hyster-Yale Materials Handling (NYSE:HY) on 3/1/2023 |
WSR Whitestone REIT | $12.55 +2.6% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Whitestone REIT (NYSE:WSR) on 3/1/2023 |
XPEL XPEL | $54.02 -3.6% | 3/1/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $104.00 | Low | View details for EF Hutton Acquisition Co. I rating of XPEL (NASDAQ:XPEL) on 3/1/2023 |
CMPS COMPASS Pathways | $8.32 -12.4% | 2/28/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $38.00 | Low | View details for EF Hutton Acquisition Co. I rating of COMPASS Pathways (NASDAQ:CMPS) on 2/28/2023 |
BCYC Bicycle Therapeutics | $24.90 +1.4% | 2/28/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $55.00 | Low | View details for EF Hutton Acquisition Co. I rating of Bicycle Therapeutics (NASDAQ:BCYC) on 2/28/2023 |
HOWL Werewolf Therapeutics | $6.48 +2.0% | 2/27/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Werewolf Therapeutics (NASDAQ:HOWL) on 2/27/2023 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 2/27/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $68.50 | Low | View details for EF Hutton Acquisition Co. I rating of Jasper Therapeutics (NASDAQ:JSPR) on 2/27/2023 |
NNVC NanoViricides | $1.16 +2.7% | 2/28/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $8.50 -> $5.25 | N/A | View details for EF Hutton Acquisition Co. I rating of NanoViricides (NYSE:NNVC) on 2/28/2023 |
AMRC Ameresco | $24.13 +6.1% | 2/28/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $86.00 -> $80.00 | Low | View details for EF Hutton Acquisition Co. I rating of Ameresco (NYSE:AMRC) on 2/28/2023 |
USEG U.S. Energy | $1.08 +1.9% | 2/28/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $4.00 -> $3.50 | Low | View details for EF Hutton Acquisition Co. I rating of U.S. Energy (NASDAQ:USEG) on 2/28/2023 |
ITRI Itron | $92.52 +1.1% | 2/28/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $60.00 | Low | View details for EF Hutton Acquisition Co. I rating of Itron (NASDAQ:ITRI) on 2/28/2023 |
CTO CTO Realty Growth | $16.95 +0.3% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 -> $23.00 | Low | View details for EF Hutton Acquisition Co. I rating of CTO Realty Growth (NYSE:CTO) on 2/24/2023 |
NTLA Intellia Therapeutics | $27.51 +1.8% | 2/24/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $123.00 -> $116.00 | Low | View details for EF Hutton Acquisition Co. I rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/24/2023 |
TNC Tennant | $121.45 0.0% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $98.00 | Low | View details for EF Hutton Acquisition Co. I rating of Tennant (NYSE:TNC) on 2/24/2023 |
GOOD Gladstone Commercial | $13.84 +2.0% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $20.00 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Gladstone Commercial (NASDAQ:GOOD) on 2/24/2023 |
REGN Regeneron Pharmaceuticals | $962.49 -0.4% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $853.00 | Low | View details for EF Hutton Acquisition Co. I rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/24/2023 |
MDV Modiv Industrial | $16.76 -2.6% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $17.00 | Low | View details for EF Hutton Acquisition Co. I rating of Modiv Industrial (NYSE:MDV) on 2/24/2023 |
XNCR Xencor | $22.13 -1.3% | 2/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $42.00 | Low | View details for EF Hutton Acquisition Co. I rating of Xencor (NASDAQ:XNCR) on 2/24/2023 |
ENVX Enovix | $8.01 -0.2% | 2/23/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Enovix (NASDAQ:ENVX) on 2/23/2023 |
LAND Gladstone Land | $13.34 +2.1% | 2/23/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $25.00 -> $22.00 | Low | View details for EF Hutton Acquisition Co. I rating of Gladstone Land (NASDAQ:LAND) on 2/23/2023 |
CRSP CRISPR Therapeutics | $68.16 -2.9% | 2/22/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $75.00 | Low | View details for EF Hutton Acquisition Co. I rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/22/2023 |
KLXE KLX Energy Services | $7.74 +6.2% | 2/22/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $30.00 | Low | View details for EF Hutton Acquisition Co. I rating of KLX Energy Services (NASDAQ:KLXE) on 2/22/2023 |
ALNY Alnylam Pharmaceuticals | $149.45 -3.2% | 2/21/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $304.00 | Low | View details for EF Hutton Acquisition Co. I rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 2/21/2023 |
VRAR The Glimpse Group | $1.12 -4.3% | 2/16/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of The Glimpse Group (NASDAQ:VRAR) on 2/16/2023 |
ELMD Electromed | $16.30 -0.7% | 2/16/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $13.50 -> $15.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Electromed (NYSE:ELMD) on 2/16/2023 |
POWW AMMO | $2.75 -3.2% | 2/16/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $6.00 -> $3.00 | Low | View details for EF Hutton Acquisition Co. I rating of AMMO (NASDAQ:POWW) on 2/16/2023 |
SDPI Superior Drilling Products | $0.91 +2.2% | 2/16/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Superior Drilling Products (NYSE:SDPI) on 2/16/2023 |
CVM CEL-SCI | $1.91 +1.1% | 2/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | N/A | View details for EF Hutton Acquisition Co. I rating of CEL-SCI (NYSE:CVM) on 2/17/2023 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 2/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $40.00 -> $68.50 | Low | View details for EF Hutton Acquisition Co. I rating of Jasper Therapeutics (NASDAQ:JSPR) on 2/17/2023 |
HOWL Werewolf Therapeutics | $6.48 +2.0% | 2/17/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Werewolf Therapeutics (NASDAQ:HOWL) on 2/17/2023 |
LTRN Lantern Pharma | $8.80 -10.0% | 2/15/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $11.00 | Low | View details for EF Hutton Acquisition Co. I rating of Lantern Pharma (NASDAQ:LTRN) on 2/15/2023 |
BCYC Bicycle Therapeutics | $24.90 +1.4% | 2/15/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $55.00 | Low | View details for EF Hutton Acquisition Co. I rating of Bicycle Therapeutics (NASDAQ:BCYC) on 2/15/2023 |
ACST Acasti Pharma | $3.45 +1.5% | 2/15/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Acasti Pharma (NASDAQ:ACST) on 2/15/2023 |
UPXI Upexi | $0.58 -6.4% | 2/15/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Upexi (NASDAQ:UPXI) on 2/15/2023 |
CYBN Cybin | $0.41 -4.7% | 2/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $3.00 | Low | View details for EF Hutton Acquisition Co. I rating of Cybin (OTCMKTS:CYBN) on 2/14/2023 |
MNPR Monopar Therapeutics | $0.68 -8.1% | 2/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Monopar Therapeutics (NASDAQ:MNPR) on 2/14/2023 |
ATLX Atlas Lithium | $17.02 +14.1% | 2/13/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $12.00 | Low | View details for EF Hutton Acquisition Co. I rating of Atlas Lithium (NASDAQ:ATLX) on 2/13/2023 |
PINE Alpine Income Property Trust | $15.27 +0.6% | 2/13/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $22.00 -> $23.00 | Low | View details for EF Hutton Acquisition Co. I rating of Alpine Income Property Trust (NYSE:PINE) on 2/13/2023 |
GFAI Guardforce AI | $3.67 +6.7% | 2/13/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $30.00 | Low | View details for EF Hutton Acquisition Co. I rating of Guardforce AI (NASDAQ:GFAI) on 2/13/2023 |
GTHX G1 Therapeutics | $4.32 -3.4% | 2/13/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $35.00 -> $19.00 | N/A | View details for EF Hutton Acquisition Co. I rating of G1 Therapeutics (NASDAQ:GTHX) on 2/13/2023 |
EXEL Exelixis | $23.73 -0.5% | 2/14/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Exelixis (NASDAQ:EXEL) on 2/14/2023 |
FLUX Flux Power | $4.43 +1.8% | 2/10/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $8.00 -> $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of Flux Power (NASDAQ:FLUX) on 2/10/2023 |
DRCT Direct Digital | $15.24 -5.0% | 2/9/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Direct Digital (NASDAQ:DRCT) on 2/9/2023 |
ATRA Atara Biotherapeutics | $0.69 -1.4% | 2/9/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Atara Biotherapeutics (NASDAQ:ATRA) on 2/9/2023 |
EXEL Exelixis | $23.73 -0.5% | 2/8/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Exelixis (NASDAQ:EXEL) on 2/8/2023 |
REGN Regeneron Pharmaceuticals | $962.49 -0.4% | 2/8/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $851.00 -> $853.00 | Low | View details for EF Hutton Acquisition Co. I rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/8/2023 |
SPI SPI Energy | $0.62 +3.3% | 2/8/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of SPI Energy (NASDAQ:SPI) on 2/8/2023 |
ITI Iteris | $4.94 -1.0% | 2/6/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $5.50 -> $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of Iteris (NASDAQ:ITI) on 2/6/2023 |
Altcoin FRENZY Alert… (Ad) Bitcoin recently crossed the highest price in its 15-year history…
Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen!
Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days…
Like Fetch.ai, that gained over 350% in just the last 30 days…
Click here now to register for the event (FOR FREE!) |
SWAG Stran & Company, Inc. | $1.46 +0.7% | 1/31/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $5.50 -> $4.50 | Low | View details for EF Hutton Acquisition Co. I rating of Stran & Company, Inc. (NASDAQ:SWAG) on 1/31/2023 |
XNCR Xencor | $22.13 -1.3% | 1/30/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $42.00 | Low | View details for EF Hutton Acquisition Co. I rating of Xencor (NASDAQ:XNCR) on 1/30/2023 |
ENVX Enovix | $8.01 -0.2% | 1/27/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $23.00 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Enovix (NASDAQ:ENVX) on 1/27/2023 |
TTI TETRA Technologies | $4.42
| 1/24/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of TETRA Technologies (NYSE:TTI) on 1/24/2023 |
MNPR Monopar Therapeutics | $0.68 -8.1% | 1/23/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Monopar Therapeutics (NASDAQ:MNPR) on 1/23/2023 |
NINE Nine Energy Service | $2.24 -0.9% | 1/23/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Nine Energy Service (NYSE:NINE) on 1/23/2023 |
SPI SPI Energy | $0.62 +3.3% | 1/18/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $8.00 -> $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of SPI Energy (NASDAQ:SPI) on 1/18/2023 |
GMGI Golden Matrix Group | $2.86 -2.7% | 1/19/2023 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $3.00 -> $4.00 | Low | View details for EF Hutton Acquisition Co. I rating of Golden Matrix Group (NASDAQ:GMGI) on 1/19/2023 |
MOD Modine Manufacturing | $95.19 -0.1% | 1/17/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $32.00 | Low | View details for EF Hutton Acquisition Co. I rating of Modine Manufacturing (NYSE:MOD) on 1/17/2023 |
GOOD Gladstone Commercial | $13.84 +2.0% | 1/13/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $21.00 -> $20.00 | Low | View details for EF Hutton Acquisition Co. I rating of Gladstone Commercial (NASDAQ:GOOD) on 1/13/2023 |
NINE Nine Energy Service | $2.24 -0.9% | 1/13/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $15.50 -> $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Nine Energy Service (NYSE:NINE) on 1/13/2023 |
EXEL Exelixis | $23.73 -0.5% | 1/11/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $28.00 -> $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Exelixis (NASDAQ:EXEL) on 1/11/2023 |
REGN Regeneron Pharmaceuticals | $962.49 -0.4% | 1/11/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $851.00 | Low | View details for EF Hutton Acquisition Co. I rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 1/11/2023 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 1/11/2023 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $40.00 | Low | View details for EF Hutton Acquisition Co. I rating of Jasper Therapeutics (NASDAQ:JSPR) on 1/11/2023 |
ATAI Atai Life Sciences | $1.97 +10.1% | 1/6/2023 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $23.00 -> $15.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Atai Life Sciences (NASDAQ:ATAI) on 1/6/2023 |
CRSP CRISPR Therapeutics | $68.16 -2.9% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $75.00 | Low | View details for EF Hutton Acquisition Co. I rating of CRISPR Therapeutics (NASDAQ:CRSP) on 1/5/2023 |
FATE Fate Therapeutics | $7.34
| 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $16.00 | Low | View details for EF Hutton Acquisition Co. I rating of Fate Therapeutics (NASDAQ:FATE) on 1/5/2023 |
REPL Replimune Group | $8.17 -1.0% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $60.00 | Low | View details for EF Hutton Acquisition Co. I rating of Replimune Group (NASDAQ:REPL) on 1/5/2023 |
CGEN Compugen | $2.58 +1.6% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Compugen (NASDAQ:CGEN) on 1/5/2023 |
GNTA Genenta Science | $3.50 -4.4% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Genenta Science (NASDAQ:GNTA) on 1/5/2023 |
GTHX G1 Therapeutics | $4.32 -3.4% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of G1 Therapeutics (NASDAQ:GTHX) on 1/5/2023 |
BCYC Bicycle Therapeutics | $24.90 +1.4% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $55.00 | Low | View details for EF Hutton Acquisition Co. I rating of Bicycle Therapeutics (NASDAQ:BCYC) on 1/5/2023 |
ALLO Allogene Therapeutics | $4.47 +0.2% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Allogene Therapeutics (NASDAQ:ALLO) on 1/5/2023 |
MRUS Merus | $45.03 +0.6% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of Merus (NASDAQ:MRUS) on 1/5/2023 |
ATRA Atara Biotherapeutics | $0.69 -1.4% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Atara Biotherapeutics (NASDAQ:ATRA) on 1/5/2023 |
BCAB BioAtla | $3.44 -0.6% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of BioAtla (NASDAQ:BCAB) on 1/5/2023 |
IPSC Century Therapeutics | $4.18 -2.1% | 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $18.00 | Low | View details for EF Hutton Acquisition Co. I rating of Century Therapeutics (NASDAQ:IPSC) on 1/5/2023 |
ADAP Adaptimmune Therapeutics | $1.58
| 1/5/2023 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 1/5/2023 |
CVM CEL-SCI | $1.91 +1.1% | 12/29/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $17.00 -> $16.00 | N/A | View details for EF Hutton Acquisition Co. I rating of CEL-SCI (NYSE:CVM) on 12/29/2022 |
AGEN Agenus | $0.58 +3.6% | 12/22/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Agenus (NASDAQ:AGEN) on 12/22/2022 |
PED PEDEVCO | $0.80
| 12/22/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.40 | N/A | View details for EF Hutton Acquisition Co. I rating of PEDEVCO (NYSEAMERICAN:PED) on 12/22/2022 |
GMGI Golden Matrix Group | $2.86 -2.7% | 12/22/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $3.00 | Low | View details for EF Hutton Acquisition Co. I rating of Golden Matrix Group (NASDAQ:GMGI) on 12/22/2022 |
KLXE KLX Energy Services | $7.74 +6.2% | 12/22/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 -> $30.00 | Low | View details for EF Hutton Acquisition Co. I rating of KLX Energy Services (NASDAQ:KLXE) on 12/22/2022 |
USEG U.S. Energy | $1.08 +1.9% | 12/21/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $4.00 | Low | View details for EF Hutton Acquisition Co. I rating of U.S. Energy (NASDAQ:USEG) on 12/21/2022 |
PINE Alpine Income Property Trust | $15.27 +0.6% | 12/21/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $22.00 | Low | View details for EF Hutton Acquisition Co. I rating of Alpine Income Property Trust (NYSE:PINE) on 12/21/2022 |
SDPI Superior Drilling Products | $0.91 +2.2% | 12/21/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $2.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Superior Drilling Products (NYSE:SDPI) on 12/21/2022 |
VRAR The Glimpse Group | $1.12 -4.3% | 12/19/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of The Glimpse Group (NASDAQ:VRAR) on 12/19/2022 |
CYBN Cybin | $0.41 -4.7% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $3.00 | Low | View details for EF Hutton Acquisition Co. I rating of Cybin (OTCMKTS:CYBN) on 12/16/2022 |
MNMD Mind Medicine (MindMed) | $9.40 -1.1% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 12/16/2022 |
CMPS COMPASS Pathways | $8.32 -12.4% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $38.00 | Low | View details for EF Hutton Acquisition Co. I rating of COMPASS Pathways (NASDAQ:CMPS) on 12/16/2022 |
GHRS GH Research | $10.66 -0.5% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $33.00 | Low | View details for EF Hutton Acquisition Co. I rating of GH Research (NASDAQ:GHRS) on 12/16/2022 |
ATAI Atai Life Sciences | $1.97 +10.1% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $23.00 | N/A | View details for EF Hutton Acquisition Co. I rating of Atai Life Sciences (NASDAQ:ATAI) on 12/16/2022 |
CMPX Compass Therapeutics | $1.98 -3.4% | 12/16/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $10.30 | Low | View details for EF Hutton Acquisition Co. I rating of Compass Therapeutics (NASDAQ:CMPX) on 12/16/2022 |
VNRX VolitionRx | $0.76 +1.3% | 12/19/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | N/A | View details for EF Hutton Acquisition Co. I rating of VolitionRx (NYSEAMERICAN:VNRX) on 12/19/2022 |
ACST Acasti Pharma | $3.45 +1.5% | 12/19/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Acasti Pharma (NASDAQ:ACST) on 12/19/2022 |
UPXI Upexi | $0.58 -6.4% | 12/19/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Upexi (NASDAQ:UPXI) on 12/19/2022 |
HOUR Hour Loop | $1.13 -8.1% | 12/15/2022 | Reiterated by | EF Hutton Acquisition Co. I | - | Buy | $5.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hour Loop (NASDAQ:HOUR) on 12/15/2022 |
UMH UMH Properties | $16.24 +2.5% | 12/13/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of UMH Properties (NYSE:UMH) on 12/13/2022 |
COEP Coeptis Therapeutics | $0.30
| 12/12/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of Coeptis Therapeutics (NASDAQ:COEP) on 12/12/2022 |
AGEN Agenus | $0.58 +3.6% | 12/8/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Agenus (NASDAQ:AGEN) on 12/8/2022 |
Major Elon Musk Crypto Leak Revealed (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
ONL Orion Office REIT | $3.51 +2.3% | 12/5/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $15.00 -> $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Orion Office REIT (NYSE:ONL) on 12/5/2022 |
LAND Gladstone Land | $13.34 +2.1% | 12/5/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $32.00 -> $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Gladstone Land (NASDAQ:LAND) on 12/5/2022 |
HOWL Werewolf Therapeutics | $6.48 +2.0% | 12/5/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $8.30 | Low | View details for EF Hutton Acquisition Co. I rating of Werewolf Therapeutics (NASDAQ:HOWL) on 12/5/2022 |
HSON Hudson Global | $17.65 -2.5% | 11/28/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $42.50 | Low | View details for EF Hutton Acquisition Co. I rating of Hudson Global (NASDAQ:HSON) on 11/28/2022 |
KLXE KLX Energy Services | $7.74 +6.2% | 11/21/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of KLX Energy Services (NASDAQ:KLXE) on 11/21/2022 |
ITI Iteris | $4.94 -1.0% | 11/21/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $35.00 | Low | View details for EF Hutton Acquisition Co. I rating of Iteris (NASDAQ:ITI) on 11/21/2022 |
SPI SPI Energy | $0.62 +3.3% | 11/17/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $9.00 -> $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of SPI Energy (NASDAQ:SPI) on 11/17/2022 |
POWW AMMO | $2.75 -3.2% | 11/16/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $9.00 -> $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of AMMO (NASDAQ:POWW) on 11/16/2022 |
GIPR Generation Income Properties | $3.83 +2.7% | 11/16/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $8.00 -> $7.00 | Low | View details for EF Hutton Acquisition Co. I rating of Generation Income Properties (NASDAQ:GIPR) on 11/16/2022 |
CMCT Creative Media & Community Trust Co. | $4.26 +1.4% | 11/16/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $9.00 -> $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of Creative Media & Community Trust Co. (NASDAQ:CMCT) on 11/16/2022 |
USEG U.S. Energy | $1.08 +1.9% | 11/15/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $7.00 -> $4.00 | Low | View details for EF Hutton Acquisition Co. I rating of U.S. Energy (NASDAQ:USEG) on 11/15/2022 |
MDV Modiv Industrial | $16.76 -2.6% | 11/15/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $21.00 -> $17.00 | Low | View details for EF Hutton Acquisition Co. I rating of Modiv Industrial (NYSE:MDV) on 11/15/2022 |
MDRR Medalist Diversified REIT | $5.77 -0.3% | 11/14/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $12.00 -> $10.00 | Low | View details for EF Hutton Acquisition Co. I rating of Medalist Diversified REIT (NASDAQ:MDRR) on 11/14/2022 |
SACH Sachem Capital | $4.44 -0.7% | 11/11/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $7.00 -> $5.50 | N/A | View details for EF Hutton Acquisition Co. I rating of Sachem Capital (NYSEAMERICAN:SACH) on 11/11/2022 |
GOOD Gladstone Commercial | $13.84 +2.0% | 11/9/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $23.00 -> $21.00 | Low | View details for EF Hutton Acquisition Co. I rating of Gladstone Commercial (NASDAQ:GOOD) on 11/9/2022 |
SGC Superior Group of Companies | $16.52 -1.0% | 11/9/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $26.00 -> $20.00 | Low | View details for EF Hutton Acquisition Co. I rating of Superior Group of Companies (NASDAQ:SGC) on 11/9/2022 |
BMEA Biomea Fusion | $14.95 -2.7% | 11/8/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $27.00 -> $22.00 | Low | View details for EF Hutton Acquisition Co. I rating of Biomea Fusion (NASDAQ:BMEA) on 11/8/2022 |
NINE Nine Energy Service | $2.24 -0.9% | 11/8/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $7.50 -> $15.50 | Low | View details for EF Hutton Acquisition Co. I rating of Nine Energy Service (NYSE:NINE) on 11/8/2022 |
OLP One Liberty Properties | $22.64 +0.8% | 11/7/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $30.00 -> $28.00 | Low | View details for EF Hutton Acquisition Co. I rating of One Liberty Properties (NYSE:OLP) on 11/7/2022 |
EVC Entravision Communications | $1.64 +0.6% | 11/7/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $14.00 -> $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Entravision Communications (NYSE:EVC) on 11/7/2022 |
SALM Salem Media Group | $0.38 +8.7% | 11/7/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $6.00 -> $5.00 | Low | View details for EF Hutton Acquisition Co. I rating of Salem Media Group (NASDAQ:SALM) on 11/7/2022 |
ITRI Itron | $92.52 +1.1% | 11/4/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $72.00 -> $60.00 | Low | View details for EF Hutton Acquisition Co. I rating of Itron (NASDAQ:ITRI) on 11/4/2022 |
ONL Orion Office REIT | $3.51 +2.3% | 11/4/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $19.00 -> $15.00 | Low | View details for EF Hutton Acquisition Co. I rating of Orion Office REIT (NYSE:ONL) on 11/4/2022 |
WLDN Willdan Group | $28.99 -0.7% | 11/4/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $32.00 -> $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of Willdan Group (NASDAQ:WLDN) on 11/4/2022 |
HDSN Hudson Technologies | $11.01 -1.2% | 11/3/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $12.00 -> $13.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hudson Technologies (NASDAQ:HDSN) on 11/3/2022 |
AMSC American Superconductor | $13.51 +0.4% | 11/3/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $15.00 -> $12.00 | Low | View details for EF Hutton Acquisition Co. I rating of American Superconductor (NASDAQ:AMSC) on 11/3/2022 |
BMEA Biomea Fusion | $14.95 -2.7% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $27.00 | Low | View details for EF Hutton Acquisition Co. I rating of Biomea Fusion (NASDAQ:BMEA) on 11/1/2022 |
REGN Regeneron Pharmaceuticals | $962.49 -0.4% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $851.00 | Low | View details for EF Hutton Acquisition Co. I rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 11/1/2022 |
NTLA Intellia Therapeutics | $27.51 +1.8% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $130.00 | Low | View details for EF Hutton Acquisition Co. I rating of Intellia Therapeutics (NASDAQ:NTLA) on 11/1/2022 |
LTRN Lantern Pharma | $8.80 -10.0% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $11.00 | Low | View details for EF Hutton Acquisition Co. I rating of Lantern Pharma (NASDAQ:LTRN) on 11/1/2022 |
JSPR Jasper Therapeutics | $29.36 +1.9% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $40.00 | Low | View details for EF Hutton Acquisition Co. I rating of Jasper Therapeutics (NASDAQ:JSPR) on 11/1/2022 |
EXEL Exelixis | $23.73 -0.5% | 11/1/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $28.00 | Low | View details for EF Hutton Acquisition Co. I rating of Exelixis (NASDAQ:EXEL) on 11/1/2022 |
GWH ESS Tech | $0.73 -2.7% | 10/28/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $6.00 | Low | View details for EF Hutton Acquisition Co. I rating of ESS Tech (NYSE:GWH) on 10/28/2022 |
ENVX Enovix | $8.01 -0.2% | 10/28/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Enovix (NASDAQ:ENVX) on 10/28/2022 |
AMPX Amprius Technologies | $2.64
| 10/28/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $14.00 | Low | View details for EF Hutton Acquisition Co. I rating of Amprius Technologies (NYSE:AMPX) on 10/28/2022 |
LXFR Luxfer | $10.37 -1.1% | 10/27/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $27.00 -> $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Luxfer (NYSE:LXFR) on 10/27/2022 |
SHFS SHF | $0.97 -3.0% | 10/26/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $10.50 | Low | View details for EF Hutton Acquisition Co. I rating of SHF (NASDAQ:SHFS) on 10/26/2022 |
ALG Alamo Group | $228.51 +1.2% | 10/19/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $195.00 | Low | View details for EF Hutton Acquisition Co. I rating of Alamo Group (NYSE:ALG) on 10/19/2022 |
SBGI Sinclair | $13.47 +2.1% | 10/5/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $40.00 -> $50.00 | Low | View details for EF Hutton Acquisition Co. I rating of Sinclair (NASDAQ:SBGI) on 10/5/2022 |
CMCT Creative Media & Community Trust Co. | $4.26 +1.4% | 9/29/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $9.00 | Low | View details for EF Hutton Acquisition Co. I rating of Creative Media & Community Trust Co. (NASDAQ:CMCT) on 9/29/2022 |
BIVI BioVie | $0.53 -1.9% | 9/28/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $14.00 -> $8.00 | Low | View details for EF Hutton Acquisition Co. I rating of BioVie (NASDAQ:BIVI) on 9/28/2022 |
XPEL XPEL | $54.02 -3.6% | 9/27/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $104.00 | Low | View details for EF Hutton Acquisition Co. I rating of XPEL (NASDAQ:XPEL) on 9/27/2022 |
TNC Tennant | $121.45 0.0% | 9/14/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $96.00 | Low | View details for EF Hutton Acquisition Co. I rating of Tennant (NYSE:TNC) on 9/14/2022 |
HQI HireQuest | $12.95 -0.9% | 9/13/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $24.00 | Low | View details for EF Hutton Acquisition Co. I rating of HireQuest (NASDAQ:HQI) on 9/13/2022 |
ELMD Electromed | $16.30 -0.7% | 9/6/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $13.50 | Low | View details for EF Hutton Acquisition Co. I rating of Electromed (NYSE:ELMD) on 9/6/2022 |
NOTE FiscalNote | $1.33
| 8/25/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $12.00 | Low | View details for EF Hutton Acquisition Co. I rating of FiscalNote (NYSE:NOTE) on 8/25/2022 |
OLP One Liberty Properties | $22.64 +0.8% | 8/25/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $30.00 | Low | View details for EF Hutton Acquisition Co. I rating of One Liberty Properties (NYSE:OLP) on 8/25/2022 |
HOUR Hour Loop | $1.13 -8.1% | 8/16/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $7.00 -> $5.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hour Loop (NASDAQ:HOUR) on 8/16/2022 |
REFI Chicago Atlantic Real Estate Finance | $15.77 +0.5% | 8/10/2022 | Target Lowered by | EF Hutton Acquisition Co. I | - | Buy | $21.00 -> $20.00 | Low | View details for EF Hutton Acquisition Co. I rating of Chicago Atlantic Real Estate Finance (NASDAQ:REFI) on 8/10/2022 |
CMT Core Molding Technologies | $18.99 +2.4% | 8/10/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $15.00 -> $16.00 | Low | View details for EF Hutton Acquisition Co. I rating of Core Molding Technologies (NYSEAMERICAN:CMT) on 8/10/2022 |
NINE Nine Energy Service | $2.24 -0.9% | 8/8/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $6.00 -> $7.50 | Low | View details for EF Hutton Acquisition Co. I rating of Nine Energy Service (NYSE:NINE) on 8/8/2022 |
LEGH Legacy Housing | $21.52 +3.2% | 8/8/2022 | Initiated by | EF Hutton Acquisition Co. I | - | Buy | $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of Legacy Housing (NASDAQ:LEGH) on 8/8/2022 |
HDSN Hudson Technologies | $11.01 -1.2% | 8/4/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $11.00 -> $12.00 | Low | View details for EF Hutton Acquisition Co. I rating of Hudson Technologies (NASDAQ:HDSN) on 8/4/2022 |
CTO CTO Realty Growth | $16.95 +0.3% | 8/1/2022 | Target Raised by | EF Hutton Acquisition Co. I | - | Buy | $24.00 -> $25.00 | Low | View details for EF Hutton Acquisition Co. I rating of CTO Realty Growth (NYSE:CTO) on 8/1/2022 |